Sign in
4

Changes in Ownership

NEUROCRINE BIOSCIENCES INC Filed Acc 0001209191-19-048482

Chief Legal Officer sold 6,736 shares at $100.00 ($673,600)

  • Chief Legal Officer acquired 6,736 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Lippoldt Darin · Chief Legal Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-09-03 Exercise or conversion : show line 1 in the form +6,736 $32.99 $222,221 26,839 D
2019-09-03 Sale : show line 2 in the form −6,736 $100.00 $673,600 20,103 D
Open-market sales · 6,736 sh · avg $100.00 · $673,600

Table II: Derivative

1 line
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2019-09-03 Exercise or conversion : show line 3 in the form Non-Qualified Stock Option −6,736 $32.99 $222,221 $32.99 2025-02-03 6,736 6,625 D
Loading xslF345X03/doc4.xml…